Overview of the medicine prices and availability survey methodology Presentation template for adaptation and use in medicine prices and availability survey.

Slides:



Advertisements
Similar presentations
MICS4 Survey Design Workshop Multiple Indicator Cluster Surveys Survey Design Workshop Field Staff and Field Procedures.
Advertisements

MICS4 Survey Design Workshop Multiple Indicator Cluster Surveys Survey Design Workshop MICS4 Technical Assistance.
MICS4 Survey Design Workshop Multiple Indicator Cluster Surveys Survey Design Workshop The MICS4 Process.
National experiences of regular price monitoring Klara Tisocki, WHO/HAI medicine price project Towards equitable and affordable medicine prices policy.
Medicine Prices Matter to People and Insurance Companies Margaret Ewen Health Action International.
1 Paying the Price Margaret Ewen Health Action International Europe.
1 Policy options to address access to chronic disease medicines Dr. Richard Laing Ms. Alexandra Cameron Department of Essential Medicines and Pharmaceutical.
1 Medicines for Chronic Diseases: too costly, too scarce, too important to ignore Margaret Ewen Health Action International.
Completing the Medicine Price Data Collection form Presentation template for adaptation and use in medicine prices and availability survey training workshop.
MEDICINES PRICES IN INDONESIA Ms. Selma Siahaan Center for Health Services and Technology R&D National Institute of Health R&D Indonesia 14 June 2006.
1 Data entry Presentation template for adaptation and use in medicine prices and availability survey training workshop for survey personnel Review all.
1 Medicine Prices, Availability and Affordability Margaret Ewen Health Action International.
Lebanon, 2004 Medicine price survey in Lebanon, 2004 undertaken by Dr Rita Karam, Ministry of Health Marg Ewen (on behalf of Dr Karam) WHO/HAI post-medicine.
Data collection procedures Presentation template for adaptation and use in medicine prices and availability survey training workshop for survey personnel.
Syria,2004 Medicine price survey in Syria, 2004 undertaken by Pharmaceutical Studies Directorate, Ministry of Health Presentation by Razan Sallouta WHO/HAI.
Data quality and checking Presentation template for adaptation and use in medicine prices and availability survey training workshop for survey personnel.
1 Introduction to the medicine prices and availability survey and training workshop Presentation template for adaptation and use in medicine prices and.
Mohamed Izham Mohamed Ibrahim
Measuring Medicine Prices and Availability – a new Methodology and few Indian Survey Results Dr. Anita Kotwani Department of Pharmacology Vallabhbhai Patel.
Strengthening the Pharmaceutical Sector: Mechanisms to Monitor Performance Douglas L. Keene June 15, 2010.
Multiple Indicator Cluster Surveys Survey Design Workshop MICS Technical Assistance MICS Survey Design Workshop.
Medicine prices: a WHO/Health Action International collaboration The approach, some results, and implications for policy to improve the affordability of.
Medicines Transparency Alliance (MeTA) Presented to CSO workshops during 2013 in SOLWEZI AUGUST 27 NDOLA AUGUST 29 LUSAKA OCTOBER 22.
Click a NOTUS Suite- product for a short description NOTUS REGIONAL NOTUS Regional helps regions perform the tasks related to the reimbursement of providers.
1 Medicine prices and availability, evidence for policy Technical Briefing Seminar, November 3 rd 2010 Alexandra Cameron, Department of Essential Medicines.
Rational Use of Injections within National Drug Policies World health organisation Essential Drugs and Medicines Policy Safe Injection Global Network Cairo.
E/R – ODL – UML CS145 Monday November 26 Sanaz Motahari-Asl.
Operational Material. 2 Presentation Outline Private Health Introduction Pharmaceutical Products Other Medical Products and Therapeutic Appliances Out-Patient.
1 Generating reliable evidence: measuring medicine prices and availability Dr Richard Laing Department of Essential Medicines and Pharmaceutical Policy.
Operational Material. 2 Presentation Outline Private Health Introduction Pharmaceutical Products Other Medical Products and Therapeutic Appliances Out-Patient.
1 Drug and Therapeutics Committee. Objectives  Discuss the use of aggregate data including defined daily dose in analyzing the consumption of medicines.
EDM STRATEGY FOR WORKING WITH COUNTRIES-TANZANIA Rose Shija EDM NPO TANZANIA.
Generating evidence for change: Implementing the post-ICIUM research agenda Dennis Ross-Degnan, ScD Harvard Medical School and Harvard Pilgrim Health Care.
3rd Baltic Conference on Medicines Economic Evaluation, Reimbursement and Rational Use of Pharmaceuticals Pricing and Reimbursement of Pharmaceuticals.
Repositioning Family Planning in West Africa Repositionnement de la Planification Familiale en Afrique de l’Ouest Sponsored by: U.S. Agency for International.
Paying the Price: The Affordability of Medicines Across the Commonwealth (and elsewhere) Margaret Ewen Health Action International.
WHO Level II Facility Surveys Douglas Ball Independent consultant, UK.
1 Medicine prices and availability, evidence for policy Technical Briefing Seminar, November 18 th 2009 Alexandra Cameron, Department of Essential Medicines.
TBS Seminar on Essential Medicines and Health Products Geneva, 29 October 2013 Matthew Jowett, PhD Senior Health Financing Specialist Dept. Health Systems.
EXPERIENCES IN SOUTH AFRICA WITH THE INTRODUCTION OF PHARMACEUTICAL PRICING LEGISLATION Zokufa HZ, Pillay T Pharmaceutical Policy and Planning, Department.
An-Najah National University Faculty of Engineering Industrial Engineering Department Graduation Project 1 Situational assessment for pharmaceutical sector.
ASSESSMENT OF AVAILABILITY, PRICE AND AFFORDABILITY OF MEDICINES FOR CHILDREN IN GHANA Authors: Gyansa-Lutterodt M. 1,Andrews Annan E. 2, Koduah A. 1,
The Pharmaceutical Situational Analysis in Mongolia 1 Chimedtseren Munkhdelger 1 Sanjjav Tsetsegmaa 2, 1 Ministry of Health, 2 Pharmacy School, Health.
Tanzania1. 2 Tanzania Assessment Gabriel Upunda Tanzania3 DemographicsTanzania Area (sq km)945,100 Population 32,900,000 25% urban GNP per capitaUS $240.
PRICE SURVEY HIGHLIGHTS FOR STAKEHOLDERS MEETING 16-December, 2008.
OVERVIEW OF THE ZIMBABWE NATIONAL MEDICINES POLICY Dr C E Ndhlovu, M Med Sci, FRCP Chairperson, NMTPAC Deputy Dean, UZCHS National workshop, Jan 22-23,
Medicine Prices, Availability, Affordability and Price Components in Kazakhstan, Kyrgystan, Tajikistan & Uzbekistan Margaret Ewen Health Action International.
WHO-Health Action International project on drug price comparisons A technical project of the WHO-Public interest NGO round table on access to medicines.
ACCESS TO MEDICINES - POLICY AND ISSUES
Social Pharmacy Lecture no. 6 Rational use of drugs Dr. Padma GM Rao
Availability of children’s medicines in Africa, 2007 Jane Robertson, Gilles Forte, Suzanne Hill.
Objective The aim was to assess purchasing pharmaceuticals in the public health sector in Jordan through the joint procurement for participating parties.
Paying the price: Medicine prices, availability and affordability across the globe Alexandra Cameron Department of Essential Medicines and Pharmaceutical.
1 Medicine price and availability surveys – methodology essentials – policy options Richard Laing Department of Essential Medicines and Pharmaceutical.
Medicines Transparency Alliance16/12/2015 Pricing: Observations Nazeem Mohamed Chairman, Uganda Pharmaceutical Manufacturers Association (UPMA) C.E.O.
Out-of-pocket and Out-of-reach Margaret Ewen, Coordinator, Global Projects (Pricing) Health Action International Amsterdam.
MONITORING MEDICINE AVAILABILITY AND PRICES IN UGANDA By Denis Kibira HEPS Uganda.
Marketing Career Project Renee Bass Pharmaceutical/Medical Marketing.
Indicators for monitoring and assessing pharmaceutical situation in countries Dr. Edelisa D. Carandang Drug Action Program (DAP) Essential Drugs and Medicines.
1 Medicine prices and availability, evidence for policy Technical Briefing Seminar, 2012 Richard Laing with materials provided by Alexandra Cameron, Department.
ADDRESSING PHARMACEUTICAL SUPPLY CHAIN NEEDS PRESENTATION TO HEALTH DONOR GROUP MEETING 8 July 2009.
Prepared by: Imon Rahman Lecturer Department of Pharmacy BRAC University.
R&D statistics in Denmark organization of data collection, and dissemination of R&D statistics.
Institutional Pharmacy
Inventory Management Chapter 13.
Medicine prices and availability, evidence for policy
WHO Medicines Work in Countries: The Kenya Example
Issues on Dispensing Dr Percy Mahlathi.
Ch 18: Pharmacy.
Presentation transcript:

Overview of the medicine prices and availability survey methodology Presentation template for adaptation and use in medicine prices and availability survey training workshop for survey personnel Review all slides carefully for applicability to your survey before use! Medicine prices and availability survey Training workshop Location, dates

Where will data be collected? Data is collected in 6 regions of the country ("survey areas") –Survey area 1: ADD NAME –Survey area 2: ADD NAME –Survey area 3: ADD NAME –Survey area 4: ADD NAME –Survey area 5: ADD NAME –Survey area 6: ADD NAME In each survey area, data will be collected from a pre- determined sample of medicine outlets in the following sectors: –public sector (e.g. hospitals, health centres) –private sector (e.g. licensed pharmacies, licensed drug stores) –"other 1" sector (ADD NAME, e.g. NGO, OR DELETE IF N/A) –"other 2" sector (ADD NAME, e.g. dispensing doctor OR DELETE IF N/A)

ADD Country Name Survey area 1: ADD NAME 5 public outlets 5 private outlets 5 "other 1" outlets 5 "other 2" outlets TOTAL: 20 Survey area 2: ADD NAME 5 public outlets 5 private outlets 5 "other 1" outlets 5 "other 2" outlets TOTAL: 20 Survey area 3: ADD NAME 5 public outlets 5 private outlets 5 "other 1" outlets 5 "other 2" outlets TOTAL: 20 Survey area 4: ADDNAME 5 public outlets 5 private outlets 5 "other 1" outlets 5 "other 2" outlets TOTAL: 20 Survey area 5: ADD NAME 5 public outlets 5 private outlets 5 "other 1" outlets 5 "other 2" outlets TOTAL: 20 Survey area 6: ADD NAME 5 public outlets 5 private outlets 5 "other 1" outlets 5 "other 2" outlets TOTAL: 20 Survey structure

What data will be collected? The availability and price of selected medicines in different sectors: Public sector Private sector Other Sector: Other Sector: Price to the patient Availability to patients Affordability by patients Procurement price The add-on costs of medicines as they move through the supply chain, from manufacturer to patient –Conducted separately and therefore not covered in this training workshop

What medicines will be surveyed? 50 medicines –30 pre-determined by WHO/HAI to enable international comparisons (14 global medicines and 16 regional medicines) –20 selected nationally for local importance For each medicine, two products are surveyed: 1.Originator brand – original pharmaceutical product that was first authorized for marketing, normally as a patented product Always has a brand name Does not vary from outlet to outlet Identified centrally before data collection 2.Lowest-priced generic (LPG) – products other that the originator brand that contain the same active ingredient (substance), whether marketed under another brand name or the generic name You will collect data on the generic with the lowest price found at each medicine outlet LPG product will therefore vary from outlet to outlet

How will data be collected? Data on the price and availability of medicines will be obtained by data collectors during visits to "medicine outlets" Medicine outlets are places where medicines are dispensed to patients (e.g. pharmacies, health centres) Data collectors visit medicine outlets in pairs Note: public procurement data will be obtained centrally by the survey manager During medicine outlet visits, data will be recorded on hard copy Medicine Prices Data Collection forms (1 form per outlet) When less than 50% of medicines are available at a medicine outlet, data collectors will visit a back-up facility and re-conduct the survey At the end of fieldwork, all completed forms will be entered into the electronic survey Workbook by data entry personnel Data will be entered twice and checked for errors The Workbook automatically generates analyses of the survey data

How will data be analyzed? Availability: % of outlets where medicine was found on the day of data collection Price: median local prices expressed as ratios to international reference prices Medicine Price Ratio (MPR) = median local unit price________ international reference unit price –E.g. MPR = 2 means that the local medicine price is twice that of the international reference price –MSH international reference prices used: prices offered to international not-for-profit agencies for purchase of generic products Affordability: how many days wages would the lowest paid government worker need to spend to pay for treatment? Based on the median local price of a medicine prescribed at a standard dose

Roles of survey personnel The survey advisory committee helps plan and support the survey and promote its findings The survey manager coordindates the survey at the country level. In each survey area, an area supervisor is responsible for local data collection at medicine outlets. Data collectors visit medicine outlets in pairs and gather information on the medicines found there. Data entry personnel enter the data from the hard copy data collection forms into the electronic survey Workbook

Organizational structure of the survey

Advisory Committee Membership NameOrganization

Responsibilities of the survey manager Plans and coordinates the survey: –Develops the sample of medicine outlets and finalizes list of survey medicines –Recruits, trains and supervises other survey personnel –Oversees data collection through communications with area supervisors –Conducts data quality checks on local data collection forms and electronic survey Workbook –Carries out data analysis and interpretation –Develops the survey report

Responsibilities of area supervisors Organize and supervise data collection in their survey area: –Organize data collection visits at sample medicine outlets –Prepare the necessary materials for data collection –Supervise data collection activities Make sure data collection protocols are followed Check data collection forms at the end of each day for completeness and legibility –Validate data collection by re-conducting the survey at 20% of outlets and comparing results to those of data collectors –Collect and store data collection forms, and ship them to the survey manager

Responsibilities of data collectors Visit medicine outlets and collect information on the availability and price of medicines –Visit medicine outlets and meet with contact persons –Collect data and complete the Medicine Prices Data Collection form –Make sure Local Data Collection forms are complete and legible before leaving medicine outlets – Report to the area supervisor at the end of each day of data collection.

Responsibilities of data entry personnel Enter data from the hard copy Medicine Price Data Collection Forms into the electronic survey Workbook Run the double entry program and correct any mistakes Run the data checker, identify any questionable data and report it to the survey manager

Steps in the survey 1.Survey planning (e.g. sampling, selecting medicines) 2.Preparing for data collection 3.Data collection and data checking 4.Data entry and data cleaning 5.Data analysis and interpretation 6.Development of survey report 7.Dissemination of results and follow-on activities Covered in this training workshop